CROHNS DISEASE
Clinical trials for CROHNS DISEASE explained in plain language.
Never miss a new study
Get alerted when new CROHNS DISEASE trials appear
Sign up with your email to follow new studies for CROHNS DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug guselkumab shows promise for Crohn's in early trial
Disease control CompletedThis phase 3 study tested the safety of guselkumab in 38 people with moderate-to-severe Crohn's disease. Participants received the drug first through an IV, then as injections. The main goal was to track side effects, but researchers also looked at whether symptoms improved. Resu…
Matched conditions: CROHNS DISEASE
Phase: PHASE3 • Sponsor: Janssen Pharmaceutical K.K. • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
New biologic AZD7798 tested in early Crohn's trial
Disease control CompletedThis early-stage study tested a new biologic drug called AZD7798 in 112 people, including healthy volunteers and patients with Crohn's disease. The main goal was to check if the drug is safe and how the body processes it. Researchers gave single or repeated doses and monitored fo…
Matched conditions: CROHNS DISEASE
Phase: PHASE1 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
Real-World surgery study aims to improve fistula care
Knowledge-focused CompletedThis study tracked 646 people with complex fistulas (abnormal tunnels) caused by Crohn's disease or other conditions. Researchers observed the standard surgical treatments patients received at their clinics and recorded outcomes like fistula closure and complications. The goal is…
Matched conditions: CROHNS DISEASE
Sponsor: Takeda • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:28 UTC
-
Real-World study tracks how IBD patients choose between IV and injectable vedolizumab
Knowledge-focused CompletedThis study observed 92 adults with Crohn's disease or ulcerative colitis who were receiving vedolizumab either as an intravenous infusion or a subcutaneous injection. Researchers tracked treatment patterns, such as whether patients stayed on their current form or switched, over 1…
Matched conditions: CROHNS DISEASE
Sponsor: Takeda • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:07 UTC